Medicine and Dentistry
COVID-19
90%
Severe Acute Respiratory Syndrome Coronavirus 2
80%
Patient
77%
Neutralizing Antibody
66%
Antibody
55%
Vaccine
50%
Assay
46%
Infection
43%
Antigen
43%
Diagnosis
34%
Blood Stasis
28%
Laboratory
27%
Antibody Response
24%
Thrombosis
23%
Humoral Immunity
22%
Immunoglobulin G
22%
COVID-19 Vaccination
21%
Syndrome
18%
Thrombocytopenia
18%
Woman
18%
Protein
17%
Immunoglobulin G Antibody
17%
Immunoassay
17%
Neutrophil
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Virus Nucleocapsid
15%
Virus Neutralization
15%
Messenger RNA
13%
COVID-19 Vaccine
13%
Fibrinogen
13%
Therapeutic Procedure
13%
Enzyme Linked Immunosorbent Assay
11%
Serum
11%
Drug Dose Regimen
11%
mRNA Vaccine
11%
Immunoglobulin A
10%
Virus
10%
Omicron Coronavirus Variant
10%
Biological Marker
10%
Blood
9%
Immune System
9%
Case Report
9%
Observational Study
9%
Coagulopathy
9%
Hospital
9%
Age
9%
Immunogenicity
9%
Cytokine Response
9%
Cells
9%
Transplantation
9%
Lung
9%
Septic Shock
9%
Nucleosome
9%
Systematic Review
9%
Laboratory Medicine
9%
Experience
9%
Immunoglobulin M Antibody
9%
Neonates
9%
Inpatient
9%
Cellular Immunity
9%
Plasma
8%
Wassermann Test
8%
In Vitro
7%
Immune Response
7%
Heparin
7%
Fibrinolysis
7%
Extracellular Trap
7%
Histone
7%
Platelet
7%
Blood Sampling
6%
Body Mass Index
6%
Molecular Diagnosis
6%
Serositis
6%
Thromboembolism
6%
Anticoagulation
6%
Analysis
5%
Reverse Transcription Polymerase Chain Reaction
5%
Symptom
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Neutralizing Antibody
76%
Monospecific Antibody
73%
Antigen
55%
Sample
51%
Vaccine Efficacy
45%
COVID-19
42%
Immunoglobulin G Antibody
33%
Binding Antibody
26%
Omicron Coronavirus Variant
25%
Breakthrough Infection
23%
Dose
21%
Kinetics
19%
Immunoglobulin M Antibody
18%
Humoral Immunity
16%
Immunoassay
16%
Virus Nucleocapsid
15%
Dynamics
15%
Spike
14%
Antibody Response
14%
Viral Load
13%
Time
12%
NETosis
10%
ELISA
10%
Reverse Transcription Polymerase Chain Reaction
10%
Life
9%
Immune System
9%
Recognition
9%
Lung Transplantation
9%
Immunogenicity
9%
Respiratory Syncytial Virus
9%
Influenza
9%
Experience
9%
Inflammation
9%
Adoptive Immunity
9%
Neutralization
7%
Immunoassay
7%
Neutrophil Granulocyte
7%
Drug Dose Regimen
6%
Pregnancy
6%
Immunoglobulin M
6%
Virus Neutralization
6%
Cross-Reactivity
5%
Titer
5%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
70%
Sample
38%
Antibody
37%
Hemostasis
28%
Kinetics
17%
Reverse Transcription Polymerase Chain Reaction
16%
Virus Load
14%
Thrombin
13%
Immunoglobulin G
13%
Fibrinolysis
12%
Molecular Array
9%
Laboratory Technique
9%
Nucleosome
9%
Neutralizing Antibody
9%
Recognition
9%
Immunoglobulin M
9%
Coronavirinae
9%
Blood Level
9%
Experience
9%
Quantitative Technique
9%
Heparin
8%
Time
7%
Histone
7%
Life
6%
Protein
6%
Virus Nucleocapsid
6%
Coagulation
6%
Dose
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Humoral Immunity
5%